TITLE

Daily pill can end HIV epidemic

AUTHOR(S)
Coghlan, Andy; MacKenzie, Debora
PUB. DATE
July 2011
SOURCE
New Scientist;7/23/2011, Vol. 211 Issue 2822, p6
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses antiretroviral drugs (ARVs), drugs which may be able to help people who have been infected with HIV live longer and prevent people from being infected with the disease. Two studies presented at an HIV and AIDS conference in Rome, Italy showed that pre-exposure prophylaxis (PrEP) and treatment as prevention (TasP) could both be effective methods for stopping the spread of HIV. Drug resistance, ARV supplies, and the effectiveness of these treatments are examined. INSET: CHEAP DRUGS FOR THOSE IN NEED.
ACCESSION #
65217039

 

Related Articles

  • Interplay Between Transmitted and Acquired HIV Type 1 Drug Resistance: Reasons for a Disconnect. De Luca, Andrea; Zazzi, Maurizio // Journal of Infectious Diseases;7/1/2015, Vol. 212 Issue 1, p5 

    The author discusses interplay between transmitted and acquired Human immunodeficiency viruses (HIV) Type 1 drug resistance. Topic discussed include decrease in the prevalence of acquired drug resistance (ADR) R mutations in patients with virological failure while receiving antiretroviral...

  • Characterizing HIV Transmission Networks Across the United States. Aldous, Jeannette L.; Pond, Sergei Kosakovsky; Poon, Art; Jain, Sonia; Qin, Huifang; Kahn, James S.; Kitahata, Mari; Rodriguez, Benigno; Dennis, Ann M.; Boswell, Stephen L.; Haubrich, Richard; Smith, Davey M. // Clinical Infectious Diseases;Oct2012, Vol. 55 Issue 8, p1135 

    Background. Clinically, human immunodeficiency virus type 1 (HIV-1) pol sequences are used to evaluate for drug resistance. These data can also be used to evaluate transmission networks and help describe factors associated with transmission risk.Methods. HIV-1 pol sequences from participants at...

  • Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy. Sigal, Alex; Kim, Jocelyn T.; Balazs, Alejandro B.; Dekel, Erez; Mayo, Avi; Milo, Ron; Baltimore, David // Nature;9/1/2011, Vol. 477 Issue 7362, p95 

    Latency and ongoing replication have both been proposed to explain the drug-insensitive human immunodeficiency virus (HIV) reservoir maintained during antiretroviral therapy. Here we explore a novel mechanism for ongoing HIV replication in the face of antiretroviral drugs. We propose a model...

  • Transmitted Antiretroviral Drug Resistance Among Drug-Naive Female Sex Workers With Recent Infection in Kampala, Uganda. Ssemwanga, Deogratius; Ndembi, Nicaise; Lyagoba, Frederick; Magambo, Brian; Kapaata, Anne; Bukenya, Justine; Lubega, George W.; Bertagnolio, Silvia; Vandepitte, Judith; Grosskurth, Heiner; Kaleebu, Pontiano // Clinical Infectious Diseases;May2012 Supplement 4, Vol. 54 Issue suppl_4, pS339 

    During 2006–2007, transmitted human immunodeficiency virus (HIV) drug resistance (TDR) among drug-naive women with newly diagnosed HIV infection and likely to be recently infected when attending antenatal clinics in Entebbe was found to be <5% with use of the World Health Organization...

  • Surveillance of Transmitted HIV-1 Drug Resistance in Gauteng and KwaZulu-Natal Provinces, South Africa, 2005–2009. Hunt, G. M.; Ledwaba, J.; Basson, A. E.; Moyes, J.; Cohen, C.; Singh, B.; Bertagnolio, S.; Jordan, M. R.; Puren, A.; Morris, L. // Clinical Infectious Diseases;May2012 Supplement 4, Vol. 54 Issue suppl_4, pS334 

    Surveillance of human immunodeficiency virus type 1 transmitted drug resistance (TDR) was conducted among pregnant women in South Africa over a 5-year period after the initiation of a large national antiretroviral treatment program. Analysis of TDR data from 9 surveys conducted between 2005 and...

  • Development and Evaluation of a National Reference Panel of HIV-1 Protease and Reverse Transcriptase Drug-Resistance Mutations for HIV-1 Genotypic Resistance Assays in China. Sihong Xu; Jingyun Li; Zuoyi Bao; Hui Xing; Ping Zhong; Hanping Li; Haiwei Zhou; Xinping Li; Wu, Sharon; Aijing Song; Xiuhua Li; Jianhui Nie; Youchun Wang // Molecular Diagnosis & Therapy;Feb2010, Vol. 14 Issue 1, p31 

    Background: Transmission of antiretroviral drug-resistant strains of HIV-1 has a major impact on the success of HIV treatment regimens in most countries where antiretroviral therapy (ART) is available. It is now recommended that HIV-1 drug resistance be monitored in order to recommend...

  • Analyses of HIV-1 Drug-Resistance Profiles Among Infected Adolescents Experiencing Delayed Antiretroviral Treatment Switch After Initial Nonsuppressive Highly Active Antiretroviral Therapy. Agwu, Allison; Lindsey, Jane C.; Fergusson, Kimberly; Zhang, Haili; Spector, Stephen; Rudy, Bret J.; Ray, Stuart C.; Douglas, Steven D.; Flynn, Patricia M.; Persaud, Deborah // AIDS Patient Care & STDs;Jul2008, Vol. 22 Issue 7, p545 

    Treatment failure and drug resistance create obstacles to long-term management of HIV-1 infection. Nearly 60% of infected persons fail their first highly active antiretroviral therapy (HAART) regimen, partially because of nonadherence, requiring a switch to a second regimen to prevent drug...

  • Assessing HIV resistance in developing countries: Brazil as a case study. Petersen, Maya L.; Boily, Marie-Claude; Bastos, Francisco I. // Revista Panamericana de Salud Publica;Mar2006, Vol. 19 Issue 3, p146 

    Increased transmission of resistant HIV has been raised as a potential consequence of expanded access to antiretroviral therapy. We review how limitations in resources and health care infrastructure may impact the transmission of resistant HIV, and we examine data from Brazil as a case study. We...

  • Effect of misclassification of antiretroviral treatment status on the prevalence of transmitted HIV-1 drug resistance.  // BMC Medical Research Methodology;2012, Vol. 12 Issue 1, p30 

    The article presents an analysis on the impact of misclassification of antiretroviral treatment (ART) status on the prevalence of transmitted HIV-1 drug resistance (TDR). It was found that the observed rate of TDR was higher than actual TDR in the case of misclassification, and it increased with...

  • First Line Treatment Response in Patients with Transmitted HIV Drug Resistance and Well Defined Time Point of HIV Infection: Updated Results from the German HIV-1 Seroconverter Study. zu Knyphausen, Fabia; Scheufele, Ramona; Kücherer, Claudia; Jansen, Klaus; Somogyi, Sybille; Dupke, Stephan; Jessen, Heiko; Schürmann, Dirk; Hamouda, Osamah; Meixenberger, Karolin; Bartmeyer, Barbara // PLoS ONE;May2014, Vol. 9 Issue 5, p1 

    Background: Transmission of drug-resistant HIV-1 (TDR) can impair the virologic response to antiretroviral combination therapy. Aim of the study was to assess the impact of TDR on treatment success of resistance test-guided first-line therapy in the German HIV-1 Seroconverter Cohort for patients...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics